Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from COSCIENS Biopharma ( (TSE:CSCI) ).
COSCIENS Biopharma Inc. reported a significant reduction in operating expenses by 59% in Q3 2025 compared to Q3 2024, following a restructuring and zero-based budgeting initiative. The company voluntarily delisted from Nasdaq, maintaining its TSX listing, and applied for trading on the OTCQB® Venture Market, as part of a strategic move to reduce costs and enhance competitiveness.
More about COSCIENS Biopharma
COSCIENS Biopharma Inc. is a life science company focused on natural ingredients and pharmaceutical solutions. The company operates in markets such as cosmeceutical, personal care, veterinary health, and is exploring opportunities in food and beverage, dermatology, and pharmaceutical markets.
Average Trading Volume: 3,716
Technical Sentiment Signal: Sell
Current Market Cap: C$10.87M
For an in-depth examination of CSCI stock, go to TipRanks’ Overview page.